Arrowhead Pharmaceuticals (ARWR) Q4 2018 Earnings

11DecConfirmed
Q1 2018
Q2 2018
Q3 2018
Q4 2018
-0.19
-0.15
-0.12
-0.08

Details

Expected EPS
-0.08
Actual EPS
-0.12
Surprise EPS
-0.04
Surprise Percent
+50%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.12 per share for Q4 2018.

0 Comments

Share your thoughts